OpenURL Connection Search

Select item for more details and to access through your institution.

Additional Value of CSF Amyloid-β {40} Levels in the Differentiation between FTLD and Control Subjects.
Published in:
Journal of Alzheimer's Disease, 2010, v. 20, n. 2, p. 445, doi. 10.3233/JAD-2010-1392
By:
- Verwey, Nicolaas A.;
- Kester, Maartje I.;
- van der Flier, Wiesje M.;
- Veerhuis, Robert;
- Berkhof, Hans;
- Twaalfhoven, Harry;
- Blankenstein, Marinus A.;
- Scheltens, Philip;
- Pijnenburg, Yolande A. L.
Publication type:
Article
Neuropathology of FMR1‐premutation carriers presenting with dementia and neuropsychiatric symptoms: Human neuropathology/other.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044916
By:
- Dijkstra, Anke A.;
- Haify, Saif;
- Verwey, Nicolaas A.;
- Prins, Niels D.;
- van der Toorn, Esmay;
- Rozemuller, Annemieke J.M.;
- Bugiani, Marianna;
- den Dunnen, Wilfred;
- Todd, Peter K.;
- Charlet‐Berguerand, Nicolas;
- Willemsen, Rob;
- Hukema, Renate;
- Hoozemans, Jeroen J.M.
Publication type:
Article
P2‐365: ADDED DIAGNOSTIC VALUE OF 18F‐FLUTEMETAMOL PET SCANNING IN YOUNG PATIENTS WITH DEMENTIA.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P740, doi. 10.1016/j.jalz.2019.06.2772
By:
- Handels, Ron;
- Zwan, Marissa D.;
- Pelkmans, Wiesje;
- Bouwman, Femke H.;
- Biessels, Geert Jan;
- Roks, Gerwin;
- Schoonenboom, Niki S.M.;
- Verwey, Nicolaas A.;
- Van Berckel, Bart N.M.;
- van der Flier, Wiesje M.;
- Verhey, Frans R.J.;
- Scheltens, Philip
Publication type:
Article
P1‐433: DECREASED CSF AMYLOID BETA 38, 40 AND 42 IN GENETICALLY AND PATHOLOGICALLY CONFIRMED FTD.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P431, doi. 10.1016/j.jalz.2019.06.1038
By:
- Verwey, Nicolaas A.;
- Teunissen, Charlotte E.;
- Hoozemans, Jeroen J.M.;
- Rozemuller, Annemieke M.;
- Scheltens, Philip;
- Pijnenburg, Yolande A.L.
Publication type:
Article
O2‐09‐03: DIAGNOSTIC PERFORMANCE OF ELECSYS IMMUNOASSAYS FOR CEREBROSPINAL FLUID ALZHEIMER'S DISEASE BIOMARKERS IN A NON‐ACADEMIC MULTICENTER MEMORY CLINIC COHORT: THE ABIDE PROJECT.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P641, doi. 10.1016/j.jalz.2018.06.2690
By:
- Willemse, Eline A.J.;
- van Maurik, Ingrid S.;
- Tijms, Betty M.;
- Franke, Andreas;
- Hubeek, Isabelle;
- Boelaarts, Leo;
- Claus, Jules J.;
- Korf, Esther S.C.;
- Van Marum, Rob J.;
- Roks, Gerwin;
- Schoonenboom, Niki S.M.;
- Verwey, Nicolaas;
- Wahl, Simone;
- Van der Flier, Wiesje M.;
- Teunissen, Charlotte E.
Publication type:
Article
Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements.
Published in:
Clinical Chemistry & Laboratory Medicine, 2008, v. 46, n. 9, p. 1300, doi. 10.1515/CCLM.2008.241
By:
- Verwey, Nicolaas A.;
- Bouwman, Femke H.;
- van der Flier, Wiesje M.;
- Veerhuis, Rob;
- Scheltens, Philip;
- Blankenstein, Marinus A.
Publication type:
Article
Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. 3, p. 269, doi. 10.1016/j.jalz.2011.12.007
By:
- Koedam, Esther L.G.E.;
- van der Vlies, Annelies E.;
- van der Flier, Wiesje M.;
- Verwey, Nicolaas A.;
- Koene, Ted;
- Scheltens, Philip;
- Blankenstein, Marinus A.;
- Pijnenburg, Yolande A.L.
Publication type:
Article
Relationship of cerebrospinal fluid biomarkers with in vivo [11C]PIB and [18F]FDDNP binding
Published in:
2009
By:
- van Berckel, Bart N.M.;
- Tolboom, Nelleke;
- van der Flier, Wiesje M.;
- Yaqub, Maqsood;
- Boellaard, Ronald;
- Verwey, Nicolaas A.;
- Blankenstein, Marinus A.;
- Luurtsema, Gert;
- Windhorst, Albert D.;
- Lammertsma, Adriaan A.;
- Scheltens, Philip
Publication type:
Abstract
P3-100: Variability in longitudinal CSF Tau and phosporylated Tau measurements
Published in:
2008
By:
- Verwey, Nicolaas A.;
- Bouwman, Femke H.;
- Veerhuis, Robert;
- Scheltens, Philip;
- Van der Flier, Wiesje M.;
- Blankenstein, Marinus A.
Publication type:
Abstract
P3-099: Serum Amyloid P component as biomarker in Alzheimer's disease
Published in:
2008
By:
- Veerhuis, Robert;
- Verwey, Nicolaas A.;
- Schuitemaker, Alie;
- Van der Vlier, Wiesje M.;
- Mulder, Cees;
- Hack, C. Erik;
- Scheltens, Philip;
- Blankenstein, Marinus A.
Publication type:
Abstract
P1-371: New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population
Published in:
2008
By:
- Bouwman, Femke H.;
- Verwey, Nicolaas A.;
- Klein, Martin;
- Pijnenburg, Yolande A.L.;
- Kok, Astrid;
- Blankenstein, Marinus A.;
- Sluimer, Jasper D.;
- Barkhof, Frederik;
- Van der Flier, Wiesje M.;
- Scheltens, Philip
Publication type:
Abstract
Recognition of cognitive dysfunction in hospitalised older patients: a flash mob study.
Published in:
BMC Geriatrics, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12877-023-04588-5
By:
- Visser, Fleur C. W.;
- van Eersel, Marlise E. A.;
- Hempenius, Liesbeth;
- Verwey, Nicolaas A.;
- Band, Caterina;
- van der Bol, Jessica M.;
- Boudestein, Kris;
- van Dijk, Suzanne C.;
- Gobbens, Robbert;
- van der Hooft, Cornelis S.;
- Kamper, Adriaan M.;
- Ruiter, Rikje;
- Sipers, Walther;
- Spoelstra, Birgit N. A.;
- Stoffels, Josephine;
- Stolwijk-Woudstra, Dyane J.;
- van Stralen, Karlijn J.;
- van Strien, Astrid M.;
- Wijngaarden, Marjolein A.;
- Winters, Marian
Publication type:
Article
Clinico-Pathological Correlations of the Frontal Lobe Syndrome: Results of a Large Brain Bank Study.
Published in:
Dementia & Geriatric Cognitive Disorders, 2015, v. 40, n. 3/4, p. 121, doi. 10.1159/000430460
By:
- Krudop, Welmoed a.;
- Bosman, Sjanne;
- Geurts, Jeroen J.G.;
- Sikkes, Sietske a.M.;
- Verwey, Nicolaas a.;
- Stek, Max L.;
- Scheltens, Philip;
- Rozemuller, annemieke J.M.;
- Pijnenburg, Yolande a.L.
Publication type:
Article
Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease.
Published in:
Dementia & Geriatric Cognitive Disorders, 2008, v. 26, n. 6, p. 522, doi. 10.1159/000178756
By:
- Verwey, Nicolaas A.;
- Schuitemaker, Alie;
- Van der Flier, Wiesje M.;
- Mulder, Sandra D.;
- Mulder, Cees;
- Hack, C. Erik;
- Scheltens, Philip;
- Blankenstein, Marinus A.;
- Veerhuis, Robert
Publication type:
Article
Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease.
Published in:
Clinical Chemistry, 2010, v. 56, n. 2, p. 248, doi. 10.1373/clinchem.2009.130518
By:
- Mulder, Cees;
- Verwey, Nicolaas A.;
- van der Flier, Wiesje M.;
- Bouwman, Femke H.;
- Kok, Astrid;
- van Elk, Evert J.;
- Scheltens, Philip;
- Blankenstein, Marinus A.
Publication type:
Article
Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding.
Published in:
Journal of Nuclear Medicine, 2009, v. 50, n. 9, p. 1464, doi. 10.2967/jnumed.109.064360
By:
- Tolboom, Nelleke;
- van der Flier, Wiesje M.;
- Yaqub, Maqsood;
- Boellaard, Ronald;
- Verwey, Nicolaas A.;
- Blankenstein, Marinus A.;
- Windhorst, Albert D.;
- Scheltens, Philip;
- Lammertsma, Adriaan A.;
- van Berckel, Bart N. M.
Publication type:
Article
Young‐onset dementia in memory clinics in the Netherlands: Study design and description of PRECODE‐GP.
Published in:
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 3, p. 1, doi. 10.1002/dad2.12471
By:
- van Gils, Aniek M.;
- Rhodius‐Meester, Hanneke F. M.;
- Leeuwis, Anna E.;
- Handgraaf, Dédé;
- Bakker, Christian;
- Peetoom, Kirsten;
- Bouwman, Femke H.;
- Pijnenburg, Yolande A. L.;
- Papma, Janne M.;
- Hoogendoorn, Tanja‐Anne;
- Schoonenboom, Niki;
- van Strien, Astrid;
- Verwey, Nicolaas A.;
- Köhler, Sebastian;
- de Vugt, Marjolein E.;
- van der Flier, Wiesje M.
Publication type:
Article
The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study.
Published in:
Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01588-4
By:
- Vermeiren, Marie R.;
- Somsen, Joost;
- Luurtsema, Gert;
- Reesink, Fransje E.;
- Verwey, Nicolaas A.;
- Hempenius, Liesbeth;
- Tolboom, Nelleke;
- Biessels, Geert Jan;
- Biesbroek, J. Matthijs;
- Vernooij, Meike W.;
- Veldhuijzen van Zanten, Sophie E. M.;
- Seelaar, Harro;
- Coomans, Emma M.;
- Teunissen, Charlotte E.;
- Lemstra, Afina W.;
- van Harten, Argonde C.;
- Visser, Leonie N. C.;
- van der Flier, Wiesje M.;
- van de Giessen, Elsmarieke;
- Ossenkoppele, Rik
Publication type:
Article
Cerebrospinal Fluid β-Amyloid and Tau Are Not Associated with Risk of Delirium: A Prospective Cohort Study in Older Adults with Hip Fracture.
Published in:
2011
By:
- Witlox, Joost;
- Kalisvaart, Kees J.;
- de Jonghe, Jos F.M.;
- Verwey, Nicolaas A.;
- van Stijn, Mireille F.M.;
- Houdijk, Alexander P.J.;
- Traast, Han S.;
- MacLullich, Alasdair M.J.;
- van Gool, Willem A.;
- Eikelenboom, Piet
Publication type:
Journal Article
Cerebrospinal Fluid β-Amyloid and Tau Are Not Associated with Risk of Delirium: A Prospective Cohort Study in Older Adults with Hip Fracture.
Published in:
Journal of the American Geriatrics Society, 2011, v. 59, n. 7, p. 1260, doi. 10.1111/j.1532-5415.2011.03482.x
By:
- Witlox, Joost;
- Kalisvaart, Kees J.;
- de Jonghe, Jos F.M.;
- Verwey, Nicolaas A.;
- van Stijn, Mireille F.M.;
- Houdijk, Alexander P.J.;
- Traast, Han S.;
- MacLullich, Alasdair M.J.;
- van Gool, Willem A.;
- Eikelenboom, Piet
Publication type:
Article

Found: 20

Additional Value of CSF Amyloid-β<sub> {40}</sub> Levels in the Differentiation between FTLD and Control Subjects.

Neuropathology of FMR1‐premutation carriers presenting with dementia and neuropsychiatric symptoms: Human neuropathology/other.

P2‐365: ADDED DIAGNOSTIC VALUE OF 18F‐FLUTEMETAMOL PET SCANNING IN YOUNG PATIENTS WITH DEMENTIA.

P1‐433: DECREASED CSF AMYLOID BETA 38, 40 AND 42 IN GENETICALLY AND PATHOLOGICALLY CONFIRMED FTD.

O2‐09‐03: DIAGNOSTIC PERFORMANCE OF ELECSYS IMMUNOASSAYS FOR CEREBROSPINAL FLUID ALZHEIMER'S DISEASE BIOMARKERS IN A NON‐ACADEMIC MULTICENTER MEMORY CLINIC COHORT: THE ABIDE PROJECT.

Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements.

Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia

Relationship of cerebrospinal fluid biomarkers with in vivo [11C]PIB and [18F]FDDNP binding

P3-100: Variability in longitudinal CSF Tau and phosporylated Tau measurements

P3-099: Serum Amyloid P component as biomarker in Alzheimer's disease

P1-371: New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population

Recognition of cognitive dysfunction in hospitalised older patients: a flash mob study.

Clinico-Pathological Correlations of the Frontal Lobe Syndrome: Results of a Large Brain Bank Study.

Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease.

Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease.

Relationship of Cerebrospinal Fluid Markers to <sup>11</sup>C-PiB and <sup>18</sup>F-FDDNP Binding.

Young‐onset dementia in memory clinics in the Netherlands: Study design and description of PRECODE‐GP.

The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study.

Cerebrospinal Fluid β-Amyloid and Tau Are Not Associated with Risk of Delirium: A Prospective Cohort Study in Older Adults with Hip Fracture.

Cerebrospinal Fluid β-Amyloid and Tau Are Not Associated with Risk of Delirium: A Prospective Cohort Study in Older Adults with Hip Fracture.